Tetanus Surveillance in the United States: Trends, Risks, and Prevention

Tetanus is a severe medical emergency that requires immediate hospitalization, intensive care, and supportive treatment. While it is now rare in the United States, it remains a significant public health concern since of its high lethality and the potential for fatal complications. Understanding the current surveillance trends is essential for identifying vulnerable populations and ensuring vaccination gaps are closed.

How Tetanus is Tracked in the U.S.

Tetanus is classified as a nationally notifiable disease. The Centers for Disease Control and Prevention (CDC) monitors the disease through the National Notifiable Diseases Surveillance System (NNDSS). Under this system, local and state health departments report confirmed cases to the CDC to track disease burden and identify emerging trends.

Historical Trends and the Impact of Vaccination

The landscape of tetanus in the United States has changed dramatically over the last century. Reported cases and deaths began to decline in the early 1900s, a trend driven partly by the development and use of tetanus immune globulin (TIG).

A major turning point occurred in the 1940s when tetanus toxoid-containing vaccines became part of routine childhood vaccinations. Since 1947, these public health efforts have led to a staggering decline in the disease’s impact:

• Reported cases: Declined by more than 95%.
• Reported deaths: Declined by more than 99%.

Current Disease Burden and Recent Statistics

Despite the success of vaccination programs, sporadic cases of tetanus continue to occur. Since 2010, the U.S. Has reported fewer than 40 cases annually. But, recent data indicates a concerning uptick in infections.

Recent Case Counts

According to recent statistics, there were 15 total cases reported in 2023. By November 2024, that number rose to 30 cases, representing a doubling of cases that highlights critical gaps in vaccination coverage.

Fatality Rates

Tetanus remains one of the most lethal vaccine-preventable diseases. The overall case-fatality rate is 13.2%, with deaths averaging approximately two per year. The risk of death increases significantly with age; for individuals aged 65 years and older, the case-fatality rate rises to 31%.

Who is at Risk?

Most modern tetanus cases occur in individuals who have not maintained an adequate vaccination schedule. This includes people who:

• Never received a tetanus vaccine.
• Did not complete the primary vaccine series.
• Failed to stay up to date with 10-year booster shots.

Certain population groups face a higher risk of infection and severe outcomes, including:

• Adults aged 65, and older.
• Individuals living with diabetes.
• Injection drug users.
• Foreign-born individuals from countries with lower immunization rates.

Prevention and Clinical Management

Tetanus is caused by the bacterium Clostridium tetani, which produces a potent neurotoxin. This toxin leads to painful muscle spasms and “lockjaw.” Because the disease is a medical emergency, prompt wound care and vaccination are the primary lines of defense.

Vaccination Strategy

The CDC recommends tetanus vaccination for people of all ages. Following the standard immunization schedule and receiving booster shots every 10 years is the most effective way to prevent infection.

Emergency Treatment

When infection occurs, clinical care involves hospitalization and a combination of multiple medications and supportive care to manage the neurotoxin’s effects and stabilize the patient.

Key Takeaways

• Surveillance: Tetanus is tracked via the NNDSS and remains sporadic but serious in the U.S.
• Recent Trends: Cases doubled from 15 in 2023 to 30 through November 2024.
• Lethality: The overall fatality rate is 13.2%, jumping to 31% for those 65+.
• Prevention: Routine vaccination and 10-year boosters are critical for protection.
• High-Risk Groups: Seniors, people with diabetes, and those with incomplete vaccination records are most vulnerable.